Previous studies have also emphasized that CD8+ exhaustion, immune checkpoints, tumor-associated macrophages (TAMs) [13] and cancer-associated fibroblasts (CAFs) [14] are critical therapeutic targets. The gene discussed is CD8A; the disease is cancer.